Gain Therapeutics Inc

NEW
NAS:GANX (USA)  
$ 2.50 +0.32 (+14.68%) 04:00 PM EST
At Loss
P/B:
4.64
Market Cap:
$ 63.84M
Enterprise V:
$ 39.28M
Volume:
478.70K
Avg Vol (2M):
354.39K
Trade In:
Volume:
478.70K
At Loss
Avg Vol (2M):
354.39K

Business Description

Description
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.

Financials (Next Earnings Date:2024-11-14 Est.)

GANX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GANX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Gain Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.055
EPS (TTM) ($) -1.3
Beta 0.51
Volatility % 113.53
14-Day RSI 47.22
14-Day ATR ($) 0.272981
20-Day SMA ($) 2.38775
12-1 Month Momentum % -39.04
52-Week Range ($) 0.89 - 5.33
Shares Outstanding (Mil) 25.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gain Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Gain Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Gain Therapeutics Inc Frequently Asked Questions

What is Gain Therapeutics Inc(GANX)'s stock price today?
The current price of GANX is $2.50. The 52 week high of GANX is $5.33 and 52 week low is $0.89.
When is next earnings date of Gain Therapeutics Inc(GANX)?
The next earnings date of Gain Therapeutics Inc(GANX) is 2024-11-14 Est..
Does Gain Therapeutics Inc(GANX) pay dividends? If so, how much?
Gain Therapeutics Inc(GANX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1